Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
111,5 INR | -1,52% | +4,26% | +38,20% |
Omzet 2022 | 120 mln. 0 1,34 mln. | Omzet 2023 | 136 mln. 0 1,52 mln. | Marktkapitalisatie | 10,57 mld. 0 119 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -1,22 mld. - -13,68 mln. | Nettowinst (verlies) 2023 | -1,18 mld. - -13,26 mln. | EV/omzet 2022 | 109 x |
Nettoliquiditeiten 2022 | 472 mln. 0 5,3 mln. | Nettoliquiditeiten 2023 | 2,27 mld. 0 25,43 mln. | EV/omzet 2023 | 61,1 x |
K/w-verhouding 2022 |
-9,69
x | K/w-verhouding 2023 |
-7,31
x | Werknemers | 132 |
Dividendrendement 2022 |
1,08% | Dividendrendement 2023 |
-
| Vrij verhandelbaar | 28,95% |
Recentste transcriptie over Suven Life Sciences Limited
1 dag | -1,52% | ||
1 week | +4,26% | ||
Lopende maand | +11,81% | ||
1 maand | +12,65% | ||
3 maanden | +2,48% | ||
6 maanden | +78,81% | ||
Lopend jaar | +38,20% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 74 | 09-03-89 | |
M. Mohan Kumar
DFI | Director of Finance/CFO | - | 10-01-20 |
Shrenik Soni
CMP | Compliance Officer | - | 10-01-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 74 | 09-03-89 | |
Sudha Rani Jasti
FOU | Founder | 70 | 09-03-89 |
Director/Board Member | 70 | 30-04-10 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 117 M€ | +1,11% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 111,5 | -1,52% | 17 532 |
25-04-24 | 113,2 | +0,52% | 135 373 |
24-04-24 | 112,6 | +5,00% | 48 277 |
23-04-24 | 107,2 | +0,85% | 39 928 |
22-04-24 | 106,3 | -0,54% | 34 163 |
uitgestelde koers Bombay S.E., 26 april 2024 om 12:00 uur
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,20% | 291 mln. | |
+1,51% | 42,75 mld. | |
+8,57% | 41,34 mld. | |
+49,22% | 41,61 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |